News

J.P. Morgan Sees Strong Q2 for Eli Lilly, Maintains Overweight Rating
Eli Lilly and Company (NYSE:LLY) is one of the high-margin pharma stocks to buy now. Eli Lilly and Company (NYSE:LLY) is set ...
New Scientist2d
You don't need to take drugs like Ozempic consistently to lose weight
People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly's Zepbound
An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...
Pharmabiz5d
Lilly partners with API to launch ‘Obesity Gurukul’, a flagship continuing medical education program
Lilly partners with API to launch ‘Obesity Gurukul’, a flagship continuing medical education program: Our Bureau, Bengaluru Monday, July 14, 2025, 15:20 Hrs [IST] Eli Lilly an ...
Medical Dialogues5d
Eli Lilly collaborate with API to launch obesity Gurukul for obesity care in India
The initiative will provide practical insights into understanding of obesity pathophysiology and its management.